Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Casein kinase I isoform epsilon (CK1ε) is a serine/threonine protein kinase that plays a critical role in various cellular processes, most notably the regulation of mammalian circadian rhythms. It is a member of the casein kinase 1 family and shares high sequence similarity with CK1δ. CK1ε phosphorylates a wide array of substrates and is involved in DNA replication, DNA repair, and the modulation of cytoplasmic and nuclear signaling pathways. Due to its involvement in diverse processes, it has been implicated in cancer progression, neurodegenerative diseases, diabetes, and cartilage destruction. CKIε is considered a therapeutic target, and selective inhibitors like PF-670462 have been developed.
Inhibition of CK1ε kinase activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Casein kinase I isoform epsilon (CK1ε).